• Liquid biopsy platforms yield substantially different results

    5 days ago - By Healio

    Gonzalo Torga Kenneth Pienta
    Two commercial liquid biopsy platforms that evaluated tumor samples from the same patient population yielded significantly different results, according to study findings.
    Gonzalo Torga, MD, postdoctoral research fellow at Brady Urological Institute at Johns Hopkins, and Kenneth Pienta, MD, director of research and prostate cancer researcher at Brady Urological Institute and medical oncologist at Johns Hopkins Kimmel Cancer Center, sent identical samples from 40 men with prostate cancer for analysis by the Guardant360 and PlasmaSELECT (Personal
    Read more ...